KOFU, Giappone–(BUSINESS WIRE)–La XXI edizione del Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, ospitata da GN Corporation, Giappone e Nichi-In centre for Regenerative Medicine (NCRM), è stata vinta da Sameer Kumar Reddy e da Chava Aravind Kumar della Ka…
Category: News
Samenvatting: Academisch event NCRM NICHE van GN Corporation gedenkt de 21e verjaardag van NCRM.
KOFU, Japan–(BUSINESS WIRE)–De XXI editie van Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, georganiseerd door GN Corporation, Japan en NCRM (Nichi-In centre for Regenerative Medicine), werd gewonnen door Sameer Kumar Reddy en Chava Aravind Kumar van het …
Samenvatting: Academisch event NCRM NICHE van GN Corporation gedenkt de 21e verjaardag van NCRM.
KOFU, Japan–(BUSINESS WIRE)–De XXI editie van Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, georganiseerd door GN Corporation, Japan en NCRM (Nichi-In centre for Regenerative Medicine), werd gewonnen door Sameer Kumar Reddy en Chava Aravind Kumar van het …
Samenvatting: Academisch event NCRM NICHE van GN Corporation gedenkt de 21e verjaardag van NCRM.
KOFU, Japan–(BUSINESS WIRE)–De XXI editie van Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, georganiseerd door GN Corporation, Japan en NCRM (Nichi-In centre for Regenerative Medicine), werd gewonnen door Sameer Kumar Reddy en Chava Aravind Kumar van het …
Riassunto: NCRM NICHE, l'evento accademico di GN Corporation, rende omaggio al 21o anniversario di NCRM.
KOFU, Giappone–(BUSINESS WIRE)–La XXI edizione del Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, ospitata da GN Corporation, Giappone e Nichi-In centre for Regenerative Medicine (NCRM), è stata vinta da Sameer Kumar Reddy e da Chava Aravind Kumar della Ka…
GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
PRISM Vision Group Expands and Enhances Support for Physicians and Patients with Spectrum Vision Partners Acquisition
NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–PRISM Vision Group announced that it has acquired Spectrum Vision Partners, a practice administrative services organization.
Spontaneous Vision Recovery in LHON Is Uncommon but Possible
About 1 in 5 eyes with Leber hereditary optic neuropathy improve or maintain vision without idebenone treatment over 12 months, but worsening is more common. Medscape Medical News
Warby Parker Announces Third Quarter 2026 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2026. Highlights De…
Can Technology Restore Sight? A Clinical Update
A retinal implant may offer selected patients with geographic atrophy limited form vision, while gene-based and cortical approaches remain at earlier stages of testing. Medscape News Europe
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported financial …
Adding Oral Steroids to Eye Drops May Speed Uveitis Healing
Patients with HLA-B27 uveitis who took oral prednisone along with steroid eye drops reached complete control of inflammation about 13 days sooner than those using drops alone. Medscape Medical News
What Are Coding Auditors Looking For?
Payer audit activity is growing. Here is how practices get flagged, what auditors commonly target, and what to do to lower risk and respond if a notice arrives. Medscape Medical News
Why Daily Statins May Lower Your Patient’s Glaucoma Risk
Lower glaucoma rates among statin users offer an exciting glimpse into how treating systemic health could help preserve sight. Medscape Medical News
Why Daily Statins May Lower Your Patient’s Glaucoma Risk
Lower glaucoma rates among statin users offer an exciting glimpse into how treating systemic health could help preserve sight. Medscape Medical News
FDA Clears New Treatment Option for Severe Eye Conditions
The approval brings a more affordable treatment option to Americans living with serious retinal conditions. Medscape Medical News
IL-4/IL-13 Inhibitors: Dupilumab vs IL-13-Selective Agents
Dupixent now spans nine indications while Adbry and Ebglyss block IL-13 alone in atopic dermatitis. A clinician guide to indications, safety, interactions, and monitoring. Medscape Medical News
AAO 2026: Optimizing Treatments and New Approaches in Wet AMD
Sunir Garg, MD, explores how enhanced monitoring, gene therapy, and emerging therapeutics could improve care in wet AMD. Medscape
Exclusive-India Orders Sun Pharma to Halt Eye-care Drug Production At Plant After Quality Lapses
Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding… Reuters Health Information
Retina Photos Flag Vascular Changes in Active Steroid Users
Retinal photographs of recreational athletes reveal that active anabolic steroid users have less branching in the eye’s small arteries than nonusers, a vascular difference not seen in former users. Medscape Medical News